The DNMT3a–TET2 axis promotes oncosphere formation and enhances the tumor-reconstructing capacity of CSCs, thereby increasing HCC tolerance to sorafenib [106]. The gene discussed is DNMT3A; the disease is hepatocellular carcinoma.